The outpatient clinics market is poised for significant growth, with an estimated valuation of USD 40,761.7 million in 2023. The sector is anticipated to expand steadily, reaching an estimated USD 61,372.4 million by 2033, reflecting a compound annual growth rate (CAGR) of 4.2% during the forecast period.
Key Insights:
- Current Market Value: The outpatient clinics market is projected to be worth USD 40,761.7 million in 2023.
- Growth Projection: The market is expected to grow at a CAGR of 4.2%, potentially reaching USD 61,372.4 million by 2033.
- Market Dynamics: The anticipated growth is driven by increasing patient preference for outpatient care, advancements in medical technology, and a rising focus on cost-effective healthcare solutions.
This robust growth highlights the growing importance of outpatient clinics in the healthcare system, emphasizing their role in providing accessible, efficient, and patient-centric care.
Factors Fuelling Outpatient Clinics Market Growth
- Growth of the Global Outpatient Clinics Industry is mainly bound to various macro-economic and micro-economic factors.
- The prevalence of chronic diseases such as asthma, diabetes, depression, and congestive heart failure leads to complex and severe health problems.
- With the escalating cost of the treatment process in various healthcare organizations, patients prefer visiting outpatient clinics to access treatment.
- Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases, and cerebrovascular diseases have further led to a surge in demand for outpatient clinics globally.
- Demand for quick and effective treatment of cardiovascular diseases will continue contributing to the global market growth of outpatient disorders.
- According to a recently published report by the CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths.
- As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment processes will continue to remain high.
- These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.
- Collaborations among private insurance companies and outpatient clinics will continue to remain a major trend in the global market.
- Through collaborations, private insurance companies offer payment and services in outpatient clinics.
- Imposition of regulations such as the Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides U.S. citizens with public health insurance coverage and offers access to private health insurance services.
- Moreover, increasing employee benefits such as Employees’ health insurance by employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.
However, the Global Outpatient Clinics Industry of outpatient clinics will continue to witness inhibiting growth attributed to various factors.
The imposition of strict regulations and a limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics.
As the patients are not monitored for a long period, the risk of addiction to alcohol and drugs is projected to remain high.
Moreover, the lack of access to counselors in comparison to the residential and inpatient facilities is further projected to impede the global market growth of outpatient clinics.
Sales to Remain High Through Cardiology Specialty Areas
The prevalence of chronic and cardiovascular disorders is projected to fuel demand for multi-specialty centers globally.
In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end.
Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.
Based on specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022.
However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube